EyePoint Pharmaceuticals Inc
NASDAQ:EYPT
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
MRV Engenharia e Participacoes SA
BOVESPA:MRVE3
|
BR |
During the last 3 months EyePoint Pharmaceuticals Inc insiders bought 19.7k USD , and sold 116.7k USD worth of shares. The stock price has dropped by 14% over this period (open performance analysis).
The last transaction was made on
Apr 17, 2026
by
Ribeiro Ramiro
(Chief Commercial Officer)
, who
sold
36.6k USD
worth of 
EYPT shares.
During the last 3 months EyePoint Pharmaceuticals Inc insiders bought 19.7k USD , and sold 116.7k USD worth of shares. The stock price has dropped by 14% over this period (open performance analysis).
The last transaction was made on
Apr 17, 2026
by
Ribeiro Ramiro
(Chief Commercial Officer)
, who
sold
36.6k USD
worth of EYPT shares.
EyePoint Pharmaceuticals Inc
Glance View
EyePoint Pharmaceuticals, Inc. is a biopharmaceutical company. The company is headquartered in Watertown, Massachusetts and currently employs 122 full-time employees. The company went IPO on 2005-01-27. The Company’s lead product candidate, EYP-1901, combines a bioerodible formulation of its Durasert technology with vorolanib, a tyrosine kinase inhibitor (TKI), which has demonstrated anti-VEGF activity. The firm has two commercial products, YUTIQ and DEXYCU. YUTIQ is a non-erodible intravitreal implant containing fluocinolone acetonide (FA) lasting for up to 36 months and is indicated for the treatment of chronic non-infectious uveitis affecting the posterior segment of the eye. YUTIQ utilizes its Durasert sustained-release drug delivery technology platform. DEXYCU is an indicated for the treatment of post-operative ocular inflammation. DEXYCU utilizes its Verisome drug-delivery technology. The firm is also advancing YUTIQ 50, a six-month treatment for non-infectious uveitis affecting the posterior segment of the eye, one of the causes of blindness under a supplemental new drug application (sNDA) strategy.
What is Insider Trading?
Insider trading refers to the buying or selling of a company’s stock by individuals with access to non-public, material information about the company.
While legal insider trading occurs when insiders follow disclosure rules, illegal insider trading involves trading based on confidential information and is prohibited by law.
Why is Insider Trading Important?
It isn't a coincidence that corporate executives seem to always buy at the right times. After all, they have access to every bit of company information you could ever want.
However, the fact that company executives have unique insights doesn't mean that individual investors are always left in the dark. Insider trading data is out there for all who want to use it.
Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
